325 related articles for article (PubMed ID: 27390927)
1. Coalition of Oct4A and β1 integrins in facilitating metastasis in ovarian cancer.
Samardzija C; Luwor RB; Quinn MA; Kannourakis G; Findlay JK; Ahmed N
BMC Cancer; 2016 Jul; 16():432. PubMed ID: 27390927
[TBL] [Abstract][Full Text] [Related]
2. A critical role of Oct4A in mediating metastasis and disease-free survival in a mouse model of ovarian cancer.
Samardzija C; Luwor RB; Volchek M; Quinn MA; Findlay JK; Ahmed N
Mol Cancer; 2015 Aug; 14():152. PubMed ID: 26260289
[TBL] [Abstract][Full Text] [Related]
3. Knockdown of stem cell regulator Oct4A in ovarian cancer reveals cellular reprogramming associated with key regulators of cytoskeleton-extracellular matrix remodelling.
Samardzija C; Greening DW; Escalona R; Chen M; Bilandzic M; Luwor R; Kannourakis G; Findlay JK; Ahmed N
Sci Rep; 2017 Apr; 7():46312. PubMed ID: 28406185
[TBL] [Abstract][Full Text] [Related]
4. Expression and correlation of Lewis y antigen and integrins α5 and β1 in ovarian serous and mucinous carcinoma.
Li Q; Liu S; Lin B; Yan L; Wang Y; Wang C; Zhang S
Int J Gynecol Cancer; 2010 Dec; 20(9):1482-9. PubMed ID: 21119363
[TBL] [Abstract][Full Text] [Related]
5. Role of integrin receptors for fibronectin, collagen and laminin in the regulation of ovarian carcinoma functions in response to a matrix microenvironment.
Ahmed N; Riley C; Rice G; Quinn M
Clin Exp Metastasis; 2005; 22(5):391-402. PubMed ID: 16283482
[TBL] [Abstract][Full Text] [Related]
6. Wnt11 alters integrin and cadherin expression by ovarian cancer spheroids and inhibits tumorigenesis and metastasis.
Azimian-Zavareh V; Hossein G; Ebrahimi M; Dehghani-Ghobadi Z
Exp Cell Res; 2018 Aug; 369(1):90-104. PubMed ID: 29753625
[TBL] [Abstract][Full Text] [Related]
7. The C3G/Rap1 pathway promotes secretion of MMP-2 and MMP-9 and is involved in serous ovarian cancer metastasis.
Che YL; Luo SJ; Li G; Cheng M; Gao YM; Li XM; Dai JM; He H; Wang J; Peng HJ; Zhang Y; Li WY; Wang H; Liu B; Linghu H
Cancer Lett; 2015 Apr; 359(2):241-9. PubMed ID: 25617801
[TBL] [Abstract][Full Text] [Related]
8. Alpha2beta1 integrin affects metastatic potential of ovarian carcinoma spheroids by supporting disaggregation and proteolysis.
Shield K; Riley C; Quinn MA; Rice GE; Ackland ML; Ahmed N
J Carcinog; 2007 Jun; 6():11. PubMed ID: 17567918
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of alpha(v)beta6 integrin in serous epithelial ovarian cancer regulates extracellular matrix degradation via the plasminogen activation cascade.
Ahmed N; Pansino F; Clyde R; Murthi P; Quinn MA; Rice GE; Agrez MV; Mok S; Baker MS
Carcinogenesis; 2002 Feb; 23(2):237-44. PubMed ID: 11872628
[TBL] [Abstract][Full Text] [Related]
10. Transmigration of human ovarian adenocarcinoma cells through endothelial extracellular matrix involves alphav integrins and the participation of MMP2.
Leroy-Dudal J; Demeilliers C; Gallet O; Pauthe E; Dutoit S; Agniel R; Gauduchon P; Carreiras F
Int J Cancer; 2005 Apr; 114(4):531-43. PubMed ID: 15609323
[TBL] [Abstract][Full Text] [Related]
11. Epidermal growth factor receptor signaling and the invasive phenotype of ovarian carcinoma cells.
Alper O ; Bergmann-Leitner ES; Bennett TA; Hacker NF; Stromberg K; Stetler-Stevenson WG
J Natl Cancer Inst; 2001 Sep; 93(18):1375-84. PubMed ID: 11562388
[TBL] [Abstract][Full Text] [Related]
12. SMYD3 promotes implant metastasis of ovarian cancer via H3K4 trimethylation of integrin promoters.
Lyu T; Jiang Y; Jia N; Che X; Li Q; Yu Y; Hua K; Bast RC; Feng W
Int J Cancer; 2020 Mar; 146(6):1553-1567. PubMed ID: 31503345
[TBL] [Abstract][Full Text] [Related]
13. PRL-3 suppresses c-Fos and integrin α2 expression in ovarian cancer cells.
Liu H; Al-aidaroos AQ; Wang H; Guo K; Li J; Zhang HF; Zeng Q
BMC Cancer; 2013 Feb; 13():80. PubMed ID: 23418787
[TBL] [Abstract][Full Text] [Related]
14. Beta 1-integrins regulate the formation and adhesion of ovarian carcinoma multicellular spheroids.
Casey RC; Burleson KM; Skubitz KM; Pambuccian SE; Oegema TR; Ruff LE; Skubitz AP
Am J Pathol; 2001 Dec; 159(6):2071-80. PubMed ID: 11733357
[TBL] [Abstract][Full Text] [Related]
15. FAK Inhibition disrupts a β5 integrin signaling axis controlling anchorage-independent ovarian carcinoma growth.
Tancioni I; Uryu S; Sulzmaier FJ; Shah NR; Lawson C; Miller NL; Jean C; Chen XL; Ward KK; Schlaepfer DD
Mol Cancer Ther; 2014 Aug; 13(8):2050-61. PubMed ID: 24899686
[TBL] [Abstract][Full Text] [Related]
16. HDAC1/2 control mesothelium/ovarian cancer adhesive interactions impacting on Talin-1-α5β1-integrin-mediated actin cytoskeleton and extracellular matrix protein remodeling.
Terri M; Sandoval P; Bontempi G; Montaldo C; Tomero-Sanz H; de Turris V; Trionfetti F; Pascual-Antón L; Clares-Pedrero I; Battistelli C; Valente S; Zwergel C; Mai A; Rosanò L; Del Pozo MÁ; Sánchez-Álvarez M; Cabañas C; Tripodi M; López-Cabrera M; Strippoli R
J Exp Clin Cancer Res; 2024 Jan; 43(1):27. PubMed ID: 38254102
[TBL] [Abstract][Full Text] [Related]
17. Metastatic dissemination of human ovarian epithelial carcinoma is promoted by alpha2beta1-integrin-mediated interaction with type I collagen.
Fishman DA; Kearns A; Chilukuri K; Bafetti LM; O'Toole EA; Georgacopoulos J; Ravosa MJ; Stack MS
Invasion Metastasis; 1998; 18(1):15-26. PubMed ID: 10207247
[TBL] [Abstract][Full Text] [Related]
18. Fibrillar type I collagen matrices enhance metastasis/invasion of ovarian epithelial cancer via β1 integrin and PTEN signals.
Shen Y; Shen R; Ge L; Zhu Q; Li F
Int J Gynecol Cancer; 2012 Oct; 22(8):1316-24. PubMed ID: 23013730
[TBL] [Abstract][Full Text] [Related]
19. MMP-9, uPAR and cathepsin B silencing downregulate integrins in human glioma xenograft cells in vitro and in vivo in nude mice.
Veeravalli KK; Chetty C; Ponnala S; Gondi CS; Lakka SS; Fassett D; Klopfenstein JD; Dinh DH; Gujrati M; Rao JS
PLoS One; 2010 Jul; 5(7):e11583. PubMed ID: 20657647
[TBL] [Abstract][Full Text] [Related]
20. [LASS2/TMSG1 gene silencing promotes the invasiveness and metastatic of human prostatic carcinoma cells through increase in vacuolar ATPase activity].
Xu X; You J; Pei F
Zhonghua Bing Li Xue Za Zhi; 2014 Mar; 43(3):177-83. PubMed ID: 24842017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
